NCT05719246 Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
| NCT ID | NCT05719246 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cooper Health System |
| Condition | Irritable Bowel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2020-12-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2020-12-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Irritable Bowel Syndrome (IBS) is the most common cause of recurrent abdominal pain in children. IBS is a functional gastrointestinal disorder that is linked to motor and sensory physiology, as well as the central nervous system, that presents as abdominal pain with abnormal defecation patterns. This discomfort leads to emotional stress, decreased quality of life, and anxiety. The study proposes that yoga and mindfulness will decrease anxiety and increase quality of life for patients with IBS. The aim of this study is to measure the impact of a brief, at-home, 6-week twice per week Standardized Yoga \& Meditation Program for Stress Reduction program on anxiety, IBS symptoms, and quality of life in children ages 12-21 diagnosed with IBS.
Eligibility Criteria
Inclusion Criteria: * Patients of Cooper Pediatric Gastroenterology practice in Camden, NJ or Voorhees, NJ * Patients of Cooper Pediatric Gastroenterology practice in Voorhees, NJ * Participants 12 to 21 years old with any type of IBS diagnosis * Subjects must be able to access the internet to be able to watch the yoga videos on Youtube * Patients must complete 4 out of 6 modules to stay in the study Exclusion Criteria: * Participants under the age of 12 * Participants over the age of 21
Contact & Investigator
Alla Kushnir, MD
PRINCIPAL INVESTIGATOR
The Cooper Health System
Frequently Asked Questions
Who can join the NCT05719246 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 21 Years, studying Irritable Bowel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05719246 currently recruiting?
Yes, NCT05719246 is actively recruiting participants. Contact the research team at kushnir-alla@cooperhealth.edu for enrollment information.
Where is the NCT05719246 trial being conducted?
This trial is being conducted at Camden, United States.
Who is sponsoring the NCT05719246 clinical trial?
NCT05719246 is sponsored by The Cooper Health System. The principal investigator is Alla Kushnir, MD at The Cooper Health System. The trial plans to enroll 10 participants.